» Authors » Robert Haussmann

Robert Haussmann

Explore the profile of Robert Haussmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 115
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sander P, Sauer C, Grey A, Krukowski P, Linn J, Brandt M, et al.
Fortschr Neurol Psychiatr . 2025 Jan; PMID: 39879997
  To investigate the diagnostic value of the MTA score according to age, cerebral small vessel disease and in times of automated volumetry.  Retrospective analysis of patients with subjective cognitive decline...
2.
Ye L, Greten S, Wegner F, Doll-Lee J, Krey L, Heine J, et al.
J Neurol . 2024 Feb; 271(5):2639-2648. PMID: 38353748
Background: Multiple system atrophy (MSA) is a complex and fatal neurodegenerative movement disorder. Understanding the comorbidities and drug therapy is crucial for MSA patients' safety and management. Objectives: To investigate...
3.
Beeke M, Homeyer P, Brandt M, Donix M, Haussmann R
Fortschr Neurol Psychiatr . 2023 Dec; 91(10):e3. PMID: 38040031
No abstract available.
4.
Haussmann R, Homeyer P, Sauer C, Grey A, Krukowski P, Brandt M, et al.
Int J Geriatr Psychiatry . 2023 Oct; 38(10):e6015. PMID: 37847104
Objectives: To determine the contribution of cerebral amyloid angiopathy to cognitive impairment in MCI and dementia. Methods: Patients with subjective memory impairment (SMI), amnestic and non-amnestic mild cognitive impairment ((n)aMCI),...
5.
Greten S, Wegner F, Jensen I, Krey L, Rogozinski S, Fehring M, et al.
J Neurol . 2023 Oct; 271(2):782-793. PMID: 37803149
Background: Progressive supranuclear palsy (PSP) is usually diagnosed in elderly. Currently, little is known about comorbidities and the co-medication in these patients. Objectives: To explore the pattern of comorbidities and...
6.
Hubert M, Homeyer P, Brandt M, Donix M, Haussmann R
Fortschr Neurol Psychiatr . 2023 Jul; 91(10):414-418. PMID: 37493623
Normal pressure hydrocephalus (NPH) is prevalent in aging patient populations. Despite its clinical relevance, many patients with NPH may not receive adequate treatment. Because of the frequency of Alzheimer`s disease...
7.
Haussmann R, Donix M
Int Clin Psychopharmacol . 2023 Jan; 38(2):81-88. PMID: 36719337
Major depressive disorder and Alzheimer's disease are common among older people, frequently co-occur and severely impact the quality of life. Unfortunately, data on the efficacy of pharmacologic treatment of depressive...
8.
Schmidt S, Hancke L, Haussmann R, Luetz A
Nervenarzt . 2022 Jul; 93(9):901-911. PMID: 35867117
Circadian body and behavior rhythms serve to coordinate and maintain the physiological processes in the human body. A disruption of these rhythms frequently occurs in intensive care patients and can...
9.
Haehner A, Chen B, Espin M, Haussmann R, Matthes C, Desser D, et al.
J Alzheimers Dis . 2022 Jun; 88(2):743-755. PMID: 35694924
Background: The olfactory system is affected early in Alzheimer's disease and olfactory loss can already be observed in patients with mild cognitive impairment (MCI). Olfactory training is effective for improving...
10.
Donix M, Haussmann R, Brandt M, Linn J
Neurology . 2022 Apr; 98(23):980-981. PMID: 35387848
No abstract available.